Novartis AG Financial Liabilities
Novartis AG (NVS) had Financial Liabilities of $22.50 billion as of 2023-12-31, per its 6-K filed 2023-07-18.
Discontinued › Notes
ifrs-full:FinancialLiabilities · last filed 2023-07-18
- 2023-12-31: Financial Liabilities $22.50B.
- 2022-12-31: Financial Liabilities $22.30B.
- 2022-06-30: Financial Liabilities $23.60B.
- 2021-12-31: Financial Liabilities $25.30B.
| Period end | Financial Liabilities | Financial Liabilities as first filed |
|---|---|---|
| 2023-12-31 | $22.50B 6-K · filed 2023-07-18 | |
| 2022-12-31 | $22.30B 6-K · filed 2023-07-18 | |
| 2022-06-30 | $23.60B 6-K · filed 2022-07-19 | |
| 2021-12-31 | $25.30B 6-K · filed 2022-07-19 | |
| 2021-06-30 | $26.40B 6-K · filed 2021-07-21 | |
| 2020-12-31 | $28.30B 6-K · filed 2021-07-21 | |
| 2020-06-30 | $25.20B 6-K · filed 2020-07-21 | |
| 2019-12-31 | $22.20B 6-K · filed 2020-07-21 | $35.82B 20-F · filed 2020-01-29 |
| 2019-06-30 | $22.30B 6-K · filed 2019-07-18 | |
| 2018-12-31 | $38.91B 20-F · filed 2020-01-29 | |
| 2018-01-01 | $34.63B 20-F · filed 2019-01-30 | |
| 2017-12-31 | $34.63B 20-F · filed 2019-01-30 | |
| 2016-12-31 | $29.69B 6-K · filed 2018-01-24 |